āĻšā§āĻŽ2359 âĸ HKG
add
WuXi AppTec Ord Shs H
ā§¯ā§Ž.ā§Ŧā§Ģ$
ā§Ē āĻĄāĻŋāϏā§, ⧧⧍:ā§Ļā§Ģ:ā§Ļā§Ļ PM GMT +ā§Ž · HKD · HKG · āĻĄāĻŋāϏāĻā§āϞā§āĻŽāĻžāϰ
āĻāĻžāϞ āĻļā§āώ āϝ⧠āĻĻāĻžāĻŽā§ āĻāĻŋāϞ
⧝ā§.ā§Ēā§Ļ$
āϏāĻžāϰāĻž āĻĻāĻŋāύā§āϰ āĻā§āϰā§āĻĄāĻŋāĻā§ā§ āϏā§āĻāĻā§āϰ āĻĻāĻžāĻŽā§āϰ āĻāĻ āĻž āύāĻžāĻŽāĻžāϰ āϰā§āĻā§āĻ
⧝ā§.ā§Ēā§Ļ$ - ⧝⧝.ā§§ā§Ģ$
āϏāĻžāϰāĻž āĻŦāĻāϰā§āϰ āϰā§āĻā§āĻ
ā§Ēā§Ē.ā§Šā§Ļ$ - ⧧⧍ā§Ē.ā§ā§Ļ$
āĻŽāĻžāϰā§āĻā§āĻ āĻā§āϝāĻžāĻĒ
⧍.ā§¯ā§ŠāĻā§ HKD
āĻāĻĄāĻŧ āĻāϞāĻŋāĻāĻŽ
ā§Ģ⧝.ā§Ŧā§ŠÂ āϞāĻž
P/E āĻ
āύā§āĻĒāĻžāϤ
ā§§ā§.ā§Ģ⧝
āϞāĻā§āϝāĻžāĻāĻļ āĻĒā§āϰāĻĻāĻžāύ
ā§§.ā§Ēā§Ŧ%
āĻŦāĻžāĻāĻžāϰ āϏāĻāĻŦāĻžāĻĻ
.DJI
ā§Ļ.ā§Žā§Ŧ%
ā§§.ā§ā§§%
⧍.ā§Ļā§Ģ%
ā§Ē.ā§Ļā§Ž%
āĻĢāĻžāĻāύāĻžāύā§āϏāĻŋā§āĻžāϞ āĻĒāĻžāϰāĻĢāϰā§āĻŽā§āϝāĻžāύā§āϏ
āĻā§ā§āϰ āϏā§āĻā§āĻāĻŽā§āύā§āĻ
āĻāĻĒāĻžāϰā§āĻāύ
āύā§āĻ āĻāύāĻāĻžāĻŽ
| (CNY) | āϏā§āĻĒ ā§¨ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
|---|---|---|
āĻāĻĒāĻžāϰā§āĻāύ | ā§§.⧍ā§ĻāĻļāĻ¤Â āĻā§ | ā§§ā§Ģ.ā§§ā§Ē% |
āĻŦā§āϝāĻŦāϏāĻž āĻāĻžāϞāĻžāύā§āϰ āĻāϰāĻ | ā§§ā§Šā§Ž.ā§§ā§Â āĻā§ | â |
āύā§āĻ āĻāύāĻāĻžāĻŽ | ā§Šā§Ģā§§.ā§Ēā§Ŧ āĻā§ | â |
āύā§āĻ āĻĒā§āϰāĻĢāĻŋāĻ āĻŽāĻžāϰā§āĻāĻŋāύ | ⧍⧝.ā§§ā§Ž | â |
āĻļā§ā§āĻžāϰ āĻĒā§āϰāϤāĻŋ āĻāĻĒāĻžāϰā§āĻāύ | ā§§.⧍ā§Ē | ā§Ŧā§§.ā§Ļā§Ē% |
EBITDA | ā§Ģ⧍ā§Ļ.ā§Žā§§Â āĻā§ | â |
āĻĒā§āϰāϝā§āĻā§āϝ āĻā§āϝāĻžāĻā§āϏā§āϰ āĻšāĻžāϰ | ā§Šā§Ļ.⧧⧝% | â |
āĻŦā§āϝāĻžāϞā§āύā§āϏ āĻļāĻŋāĻ
āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ
āĻŽā§āĻ āĻĻāĻžā§
| (CNY) | āϏā§āĻĒ ā§¨ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
|---|---|---|
āĻā§āϝāĻžāĻļ āĻ āĻāĻŽ āϏāĻŽā§ā§āϰ āĻŦāĻŋāύāĻŋā§ā§āĻ | ā§Š.ā§Šā§āĻļāĻ¤Â āĻā§ | ā§§ā§Ēā§Ļ.ā§§ā§Š% |
āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ | ⧝.ā§Ēā§ŦāĻļāĻ¤Â āĻā§ | ⧍ā§.ā§Ēā§Ē% |
āĻŽā§āĻ āĻĻāĻžā§ | ⧍.ā§Šā§§āĻļāĻ¤Â āĻā§ | ⧍ā§Ē.ā§Ļā§§% |
āĻŽā§āĻ āĻāĻā§āĻāĻāĻŋ | ā§.ā§§ā§ĢāĻļāĻ¤Â āĻā§ | â |
āĻāĻāĻāϏā§āĻā§āϝāĻžāύā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāϰ | ā§¨ā§Žā§Ŧ.ā§Ģā§¨Â āĻā§ | â |
āĻĒā§āϰāĻžāĻāϏ āĻā§ āĻŦā§āĻ āϰā§āĻļāĻŋāĻ | ā§Š.ā§¯ā§Š | â |
āϏāĻŽā§āĻĒāĻĻ āĻĨā§āĻā§ āĻā§ | ⧧⧍.ā§Žā§% | â |
āĻŽā§āϞāϧāύ āĻĨā§āĻā§ āĻā§ | ā§§ā§Ģ.ā§§ā§§% | â |
āĻā§āϝāĻžāĻļ āĻĢā§āϞā§
āύāĻāĻĻā§ āĻŽā§āĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ
| (CNY) | āϏā§āĻĒ ā§¨ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
|---|---|---|
āύā§āĻ āĻāύāĻāĻžāĻŽ | ā§Šā§Ģā§§.ā§Ēā§Ŧ āĻā§ | â |
āĻ
āĻĒāĻžāϰā§āĻļāύ āĻĨā§āĻā§ āĻĒāĻžāĻā§āĻž āĻā§āϝāĻžāĻļ | ā§Šā§¯ā§Ž.ā§§ā§¯Â āĻā§ | â |
āĻŦāĻŋāύāĻŋā§ā§āĻ āĻĨā§āĻā§ āĻĒā§āϰāĻžāĻĒā§āϤ āĻā§āϝāĻžāĻļ | -ā§§ā§Ēā§Ļ.ā§Ēā§Ŧ āĻā§ | â |
āĻĢāĻžāĻāύā§āϝāĻžāύā§āϏāĻŋāĻ āĻĨā§āĻā§ āĻĒā§āϰāĻžāĻĒā§āϤ āĻā§āϝāĻžāĻļ | ā§Ģā§Šā§Ģ.⧍ā§Ļ āĻā§ | â |
āύāĻāĻĻā§ āĻŽā§āĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ | ā§ā§¯ā§¨.ā§Šā§Ģ āĻā§ | â |
āĻĢā§āϰāĻŋ āĻā§āϝāĻžāĻļ āĻĢā§āϞ⧠| -ā§§ā§Ŧā§Š.ā§Ļā§Â āĻā§ | â |
āϏāĻŽā§āĻĒāϰā§āĻā§
WuXi AppTec Co., Ltd. is a Chinese provider of contract research, development, and manufacturing, services for the pharmaceutical and life-sciences industry, headquartered in Shanghai, China. The company operates research and manufacturing facilities in Asia, North America, and Europe.
Founded in 2000 by chemist Ge Li as WuXi PharmaTech, the company expanded through acquisitions and reâlistings in 2018 after a 2015 takeâprivate. It produces a large part of the ingredients used in treatments for illnesses including leukemia, lymphoma, HIV, and obesity. Wikipedia
āϏāĻŋāĻāĻ
āϏā§āĻĨāĻžāĻĒāĻŋāϤ āĻšā§ā§āĻā§
ā§§ āĻĄāĻŋāϏā§, ⧍ā§Ļā§Ļā§Ļ
āĻā§ā§āĻŦāϏāĻžāĻāĻ
āĻāϰā§āĻŽāĻāĻžāϰā§
ā§Šā§,ā§Žā§Šā§¨